Regulation of glycogen synthase kinase-3 beta (GSK-3β) by the Akt pathway in gliomas

Journal of Clinical Neuroscience

Volumn 19, Issue 11, 2012, Pages 1558-1563

  Atkins, Ryan J ^a   Dimou, James ^a,b   Paradiso, Lucy ^a   Morokoff, Andrew P ^a,b   Kaye, Andrew H ^a,b   Drummond, Katharine J ^a,b   Hovens, Christopher M ^a,c  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b ROYAL MELBOURNE HOSPITAL   (Australia)

^c Australian Prostate Cancer Research Centre at Epworth   (Australia)

Author keywords

Akt; Glioma; GSK 3 ; LiCl; Neurosphere; Wnt

Indexed keywords

GLYCOGEN SYNTHASE KINASE 3BETA; LITHIUM CHLORIDE; PROTEIN KINASE B; PROTEIN KINASE B INHIBITOR;

ARTICLE; CELL GROWTH; CELL PROLIFERATION; CELL STRUCTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; GLIOMA; GLIOMA CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

BLOTTING, WESTERN; BRAIN NEOPLASMS; CELL ADHESION; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; COLORING AGENTS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GLIOMA; GLYCOGEN SYNTHASE KINASE 3; HUMANS; LITHIUM CHLORIDE; ONCOGENE PROTEIN V-AKT; PHOSPHORYLATION; RECEPTOR, EPIDERMAL GROWTH FACTOR; TETRAZOLIUM SALTS; THIAZOLES; WNT PROTEINS;

EID: 84867102141     PISSN: 09675868     EISSN: 15322653     Source Type: Journal    
DOI: 10.1016/j.jocn.2012.07.002     Document Type: Article

References (29)

1. H.K. Gan, A.H. Kaye, and R.B. Luwor The EGFRvIII variant in glioblastoma multiforme J Clin Neurosci 16 2009 748 754
2. J. Najbauer, P.C. Huszthy, and M.E. Barish Cellular host responses to gliomas PLoS ONE 7 2012 e35150
3. R. Stupp, W.P. Mason, and M.J. van den Bent Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma N Engl J Med 352 2005 987 996
4. S.S. Stylli, and A.H. Kaye Photodynamic therapy of cerebral glioma - a review. Part II - clinical studies J Clin Neurosci 13 2006 709 717
5. A.K. Anand, A.R. Chaudhory, and H.N. Aggarwal Survival outcome and neurotoxicity in patients of high-grade gliomas treated with conformal radiation and temozolamide J Cancer Res Ther 8 2012 50 56
6. S. Galban, B. Lemasson, and T.M. Williams DW-MRI as a biomarker to compare therapeutic outcomes in radiotherapy regimens incorporating temozolomide or gemcitabine in glioblastoma PLoS ONE 7 2012 e35857
7. S.S. Stylli, S.T. I, and A.H. Kaye Prognostic significance of Tks5 expression in gliomas J Clin Neurosci 19 2012 436 442
8. E.A. Maher, F.B. Furnari, and R.M. Bachoo Malignant glioma: genetics and biology of a grave matter Genes Dev 15 2001 1311 1333
9. B. Qiu, D. Zhang, and J. Tao Human brain glioma stem cells are more invasive than their differentiated progeny cells in vitro J Clin Neurosci 19 2012 130 134
10. M.L. Wong, A.H. Kaye, and C.M. Hovens Targeting malignant glioma survival signalling to improve clinical outcomes J Clin Neurosci 14 2007 301 308
11. C.A. Grimes, and R.S. Jope The multifaceted roles of glycogen synthase kinase 3beta in cellular signaling Prog Neurobiol 65 2001 391 426
12. R.S. Jope Lithium and GSK-3: one inhibitor, two inhibitory actions, multiple outcomes Trends Pharmacol Sci 24 2003 441 443
13. R. Nishikawa, X.D. Ji, and R.C. Harmon A mutant epidermal growth factor receptor common in human glioma confers enhanced tumorigenicity Proc Natl Acad Sci U S A 91 1994 7727 7731
14. J.B. Rubin, A.L. Kung, and R.S. Klein A small-molecule antagonist of CXCR4 inhibits intracranial growth of primary brain tumors Proc Natl Acad Sci U S A 100 2003 13513 13518
15. I. Singec, R. Knoth, and R.P. Meyer Defining the actual sensitivity and specificity of the neurosphere assay in stem cell biology Nat Methods 3 2006 801 806
16. S.J. Orena, A.J. Torchia, and R.S. Garofalo Inhibition of glycogen-synthase kinase 3 stimulates glycogen synthase and glucose transport by distinct mechanisms in 3T3-L1 adipocytes J Biol Chem 275 2000 15765 15772
17. L. Oussaief, A. Hippocrate, and V. Ramirez Phosphatidylinositol 3-kinase/Akt pathway targets acetylation of Smad3 through Smad3/CREB-binding protein interaction: contribution to transforming growth factor beta1-induced Epstein-Barr virus reactivation J Biol Chem 284 2009 23912 23924
18. D.R. Laks, M. Masterman-Smith, and K. Visnyei Neurosphere formation is an independent predictor of clinical outcome in malignant glioma Stem Cells 27 2009 980 987
19. N. Inagaki, K. Chihara, and N. Arimura CRMP-2 induces axons in cultured hippocampal neurons Nat Neurosci 4 2001 781 782
20. H. Jiang, W. Guo, and X. Liang Both the establishment and the maintenance of neuronal polarity require active mechanisms: critical roles of GSK-3beta and its upstream regulators Cell 120 2005 123 135
21. T. Yoshimura, Y. Kawano, and N. Arimura GSK-3beta regulates phosphorylation of CRMP-2 and neuronal polarity Cell 120 2005 137 149
22. Y. Fukata, T.J. Itoh, and T. Kimura CRMP-2 binds to tubulin heterodimers to promote microtubule assembly Nat Cell Biol 4 2002 583 591
23. J.A. Hartigan, and G.V. Johnson Transient increases in intracellular calcium result in prolonged site-selective increases in Tau phosphorylation through a glycogen synthase kinase 3beta-dependent pathway J Biol Chem 274 1999 21395 21401
24. M.O. Nowicki, N. Dmitrieva, and A.M. Stein Lithium inhibits invasion of glioma cells; possible involvement of glycogen synthase kinase-3 Neuro Oncol 10 2008 690 699
25. N. Xie, H. Li, and D. Wei Glycogen synthase kinase-3 and p38 MAPK are required for opioid-induced microglia apoptosis Neuropharmacology 59 2010 444 451
26. T.M. Thornton, G. Pedraza-Alva, and B. Deng Phosphorylation by p38 MAPK as an alternative pathway for GSK3beta inactivation Science 320 2008 667 670
27. Y. Fu, S. Zheng, and R. Huang A potential strategy for high-grade gliomas: combination treatment with lithium chloride and BmK CT Biotechnol Lett 34 2012 9 17
28. A.S. Rao, N. Kremenevskaja, and J. Resch Lithium stimulates proliferation in cultured thyrocytes by activating Wnt/beta-catenin signalling Eur J Endocrinol 153 2005 929 938
29. M. Hong, D.C. Chen, and P.S. Klein Lithium reduces tau phosphorylation by inhibition of glycogen synthase kinase-3 J Biol Chem 272 1997 25326 25332